Laparoscopic cholecystectomy for cholelithiasis in children with sickle cell disease

Yousef Al Talhi1, Bader Hamza Shirah2, Muteb Altowairqi3

  • 1King Abdullah International Medical Research Centre, King Saud bin Abdulaziz University for Health Sciences, P.O. Box: 65362, Jeddah, 21556, Saudi Arabia.

Insights

Pediatric patients with sickle cell disease (SCD) have a higher risk of gallstones. This review examines the safety and effectiveness of laparoscopic cholecystectomy (LC) for gallstone management in these children.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Surgical Oncology

Background:

  • Sickle cell disease (SCD) patients experience increased hemolysis, leading to elevated bilirubin and pigment gallstone formation.
  • Laparoscopic cholecystectomy (LC) is the standard for gallstone disease due to its minimally invasive benefits.
  • Evidence on LC safety and efficacy in pediatric SCD patients with gallstones is limited, with unresolved controversies.

Purpose of the Study:

  • To comprehensively review existing literature on gallstone management in pediatric SCD patients.
  • To propose evidence-based recommendations for the optimal surgical approach.
  • To address the current practice variations based on geographic SCD prevalence.

Main Methods:

  • Systematic review of published literature on laparoscopic cholecystectomy for gallstones in pediatric sickle cell disease patients.
  • Analysis of reported outcomes, complications, and benefits.
  • Synthesis of findings to inform practice recommendations.

Main Results:

  • Gallstone formation is a significant complication in pediatric SCD patients due to chronic hemolysis.
  • LC offers advantages but its specific application in pediatric SCD requires further investigation.
  • Current management strategies vary, highlighting a need for standardized evidence-based guidelines.

Conclusions:

  • Further evidence-based studies are needed to establish definitive recommendations for LC in pediatric SCD patients with gallstones.
  • Addressing the limited patient data and lack of randomized trials is crucial.
  • Standardizing management will improve outcomes for this vulnerable population.

Related Concept Videos